Nano Nuclear Energy Inc. held its 2026 Annual Meeting of Stockholders on September 15, 2026, where shareholders elected six directors to serve one-year terms. Stockholders also ratified the appointment of WithumSmith+Brown, PC as the company's independent registered public accounting firm for the fiscal year ending September 30, 2026.
Oramed Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 15, 2026, where shareholders re-elected six directors and ratified Kesselman & Kesselman as the independent auditor. Stockholders also approved an amendment to the 2019 Stock Incentive Plan to increase the authorized share pool by 3,000,000 shares and voted to hold future say-on-pay votes every three years.